SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899140-24-000705
Filing Date
2024-07-10
Accepted
2024-07-10 11:11:45
Documents
1
Period of Report
2024-06-23

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 3471
  Complete submission text file 0000899140-24-000705.txt   5226
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587
Business Address 64, CHEONHO-DAERO DONGDAEMUN-GU SEOUL M5 02587 82-2-920-8184
DONG-A ST CO., LTD (Reporting) CIK: 0001799260 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37809 | Film No.: 241109117